AGIO vs. NVO
Compare and contrast key facts about Agios Pharmaceuticals, Inc. (AGIO) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AGIO or NVO.
Key characteristics
| AGIO | NVO | |
|---|---|---|
| YTD Return | 109.65% | 33.61% |
| 1Y Return | 73.70% | 43.33% |
| 3Y Return (Ann) | 0.73% | 40.46% |
| 5Y Return (Ann) | 4.36% | 41.14% |
| 10Y Return (Ann) | 0.49% | 19.24% |
| Sharpe Ratio | 1.38 | 1.42 |
| Daily Std Dev | 51.80% | 30.62% |
| Max Drawdown | -87.36% | -51.96% |
| Current Drawdown | -65.42% | -6.39% |
Fundamentals
| AGIO | NVO | |
|---|---|---|
| Market Cap | $2.66B | $606.91B |
| EPS | -$6.50 | $2.96 |
| PEG Ratio | 0.00 | 2.09 |
| Total Revenue (TTM) | $31.31M | $258.00B |
| Gross Profit (TTM) | $23.62M | $218.09B |
| EBITDA (TTM) | -$400.72M | $130.97B |
Correlation
The correlation between AGIO and NVO is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AGIO vs. NVO - Performance Comparison
In the year-to-date period, AGIO achieves a 109.65% return, which is significantly higher than NVO's 33.61% return. Over the past 10 years, AGIO has underperformed NVO with an annualized return of 0.49%, while NVO has yielded a comparatively higher 19.24% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AGIO vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AGIO vs. NVO - Dividend Comparison
AGIO has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 0.75%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
AGIO Agios Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 0.75% | 0.71% | 0.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
AGIO vs. NVO - Drawdown Comparison
The maximum AGIO drawdown since its inception was -87.36%, which is greater than NVO's maximum drawdown of -51.96%. Use the drawdown chart below to compare losses from any high point for AGIO and NVO. For additional features, visit the drawdowns tool.
Volatility
AGIO vs. NVO - Volatility Comparison
Agios Pharmaceuticals, Inc. (AGIO) has a higher volatility of 9.53% compared to Novo Nordisk A/S (NVO) at 7.47%. This indicates that AGIO's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AGIO vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Agios Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities